IL92587A - Preparations containing 2, (3-dideoxyphorin nucleoside and inhibitor of shelforin nucleoside phosphorylchase for the treatment of retinal infections - Google Patents

Preparations containing 2, (3-dideoxyphorin nucleoside and inhibitor of shelforin nucleoside phosphorylchase for the treatment of retinal infections

Info

Publication number
IL92587A
IL92587A IL9258789A IL9258789A IL92587A IL 92587 A IL92587 A IL 92587A IL 9258789 A IL9258789 A IL 9258789A IL 9258789 A IL9258789 A IL 9258789A IL 92587 A IL92587 A IL 92587A
Authority
IL
Israel
Prior art keywords
amino
guanine
dideoxypurine
use according
purine nucleoside
Prior art date
Application number
IL9258789A
Other languages
English (en)
Hebrew (he)
Other versions
IL92587A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL92587A0 publication Critical patent/IL92587A0/xx
Publication of IL92587A publication Critical patent/IL92587A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9258789A 1988-12-14 1989-12-07 Preparations containing 2, (3-dideoxyphorin nucleoside and inhibitor of shelforin nucleoside phosphorylchase for the treatment of retinal infections IL92587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28415388A 1988-12-14 1988-12-14
US31535489A 1989-02-24 1989-02-24

Publications (2)

Publication Number Publication Date
IL92587A0 IL92587A0 (en) 1990-08-31
IL92587A true IL92587A (en) 1994-04-12

Family

ID=26962435

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9258789A IL92587A (en) 1988-12-14 1989-12-07 Preparations containing 2, (3-dideoxyphorin nucleoside and inhibitor of shelforin nucleoside phosphorylchase for the treatment of retinal infections

Country Status (10)

Country Link
EP (1) EP0374096B1 (da)
JP (1) JPH02204414A (da)
KR (1) KR900009083A (da)
AU (1) AU628113B2 (da)
CA (1) CA2005205A1 (da)
DE (1) DE58902899D1 (da)
DK (1) DK630589A (da)
IE (1) IE893991L (da)
IL (1) IL92587A (da)
NZ (1) NZ231718A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法
DK0460116T3 (da) * 1989-02-27 1998-03-30 Biocryst Pharm Inc 9-substitueret-8-usubstitueret-9-deazaguaniner
EP0465297B1 (en) * 1990-07-04 1996-01-31 Merrell Dow Pharmaceuticals Inc. 9-Purinyl phosphonic acid derivatives
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
CZ27399A3 (cs) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
EP1661896A4 (en) * 2003-08-26 2008-07-16 Teijin Pharma Ltd PYRROLOPYRIMIDINETHIONDERIVAT
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
DE102006017600A1 (de) * 2006-02-09 2007-08-16 Friedel, Ruthard, Dr. Nucleosidanaloga als Genexpressionsregulatoren bei Viren
WO2014205199A2 (en) * 2013-06-22 2014-12-24 Nitor Therapeutics Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
US10729711B2 (en) 2016-08-30 2020-08-04 University of Pittsburgh—of the Commonwealth System of Higher Education Methods for treatment using small molecule potassium-sparing diuretics and natriuretics
GB201820098D0 (en) * 2018-12-10 2019-01-23 Cambridge Entpr Ltd Methods of cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine

Also Published As

Publication number Publication date
EP0374096A1 (de) 1990-06-20
AU4607489A (en) 1990-06-21
AU628113B2 (en) 1992-09-10
DE58902899D1 (de) 1993-01-14
KR900009083A (ko) 1990-07-02
CA2005205A1 (en) 1990-06-14
JPH02204414A (ja) 1990-08-14
EP0374096B1 (de) 1992-12-02
NZ231718A (en) 1992-02-25
IE893991L (en) 1990-06-14
IL92587A0 (en) 1990-08-31
DK630589A (da) 1990-06-15
DK630589D0 (da) 1989-12-13

Similar Documents

Publication Publication Date Title
US4861759A (en) Antiviral compositions and methods
US4879277A (en) Antiviral compositions and methods
US5506213A (en) Adminstration of 2'-halo-2'-deoxy adenosine to treat inflammatory bowel disease
AU668860B2 (en) Antiviral nucleoside combination
CA1238277A (en) Antiviral nucleosides
AU622950B2 (en) Therapeutic nucleosides
CA2216634C (en) Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc
US5106837A (en) Adenosine derivatives with therapeutic activity
IL92587A (en) Preparations containing 2, (3-dideoxyphorin nucleoside and inhibitor of shelforin nucleoside phosphorylchase for the treatment of retinal infections
KR100331714B1 (ko) 디데옥시뉴클레오티드유사체를이용한바이러스감염의치료방법
CA2125054A1 (en) Antiviral agents
IE63655B1 (en) Antiviral compounds
US3758684A (en) Treating dna virus infections with amino purine derivatives
US5616566A (en) Method of inhibiting HIV replication with 2',3'-dideoxyadenosine
AU626296B2 (en) Substituted adenine derivatives useful as therapeutic agents
KEATING Antiviral agents
EP0355825A2 (en) Viral treatment system
KR960014991B1 (ko) 2',3'-디데옥시시티딘을 극히 저용량으로 함유하는 약제학적 조성물
JPH0215524B2 (da)
EP0306597A2 (en) Antiviral nucleosides
AU3731989A (en) Chemotherapeutic composition for aids
JPH0551565B2 (da)
IE880210L (en) Antiviral nucleosides

Legal Events

Date Code Title Description
KB Patent renewed